More Business Wire
View Older Stories View Newer Stories-
Odyssey Investment Partners Announces Promotions
-
France Expands National AAC Access for Agenus' Botensilimab + Balstilimab for Ovarian Cancer and Soft-Tissue Sarcomas
-
Mitsubishi Corporation Joins Starlab as Major Space Station Customer
-
Ditto Joins Zebra Technologies’ PartnerConnect Program
-
Vibrant Therapeutics Raises $61M and Appoints Han Lee, Ph.D. as Co-CEO
-
NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
-
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
-
FIS Launches Industry-First Offering Enabling Banks to Lead and Scale in Agentic Commerce
-
Precision BioSciences Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGENE-DMD for Duchenne Muscular Dystrophy
-
Independence Power Holdings, Inc. Completes Business Combination/Reverse Merger with TriUnity Business Services; Addresses Permian Basin Power Shortfall with Software-Driven Microgrids
-
Lilac and Traxys Announce Binding 10-Year Offtake Agreement for Great Salt Lake Lithium Production
-
MindMed Rebrands to Definium Therapeutics, Advancing a Leading Late-Stage Psychiatry Pipeline with Three Phase 3 Readouts Expected in 2026
-
Surya Oil & Gas Corp. Appoints CFO as Company Enters Execution Phase Across West Virginia and Texas
-
Scholar Rock Highlights 2026 Strategic Priorities
-
Novocure Announces Preliminary Full Year and Fourth Quarter 2025 Performance and Provides Company Update
-
Henry Schein Names Frederick M. Lowery as Chief Executive Officer
-
Ferring Pharmaceuticals and Theralase® Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer
-
Global Payments Completes Acquisition of Worldpay and Divestiture of Issuer Solutions Business, Creating Leading Pure-Play Commerce Solutions Provider
-
New Independent Studies: Medicare Advantage Delivers Greater Value to the Federal Government and Beneficiaries than Traditional Medicare
-
Palladyne AI Announces Commercial Availability of Palladyne IQ 2.0, Delivering Industrial Autonomy to Accelerate Defense-Industrial Modernization, Agility, and Throughput
-
TriSalus Life Sciences Announces Preliminary Fourth Quarter and Full-Year 2025 Results and 2026 Revenue Guidance
-
Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production
-
FIS Completes Strategic Acquisition of Global Payments’ Issuer Solutions Business and Sale of Worldpay Stake
-
AN2 Therapeutics Announces FDA Clearance to Proceed with 90-Patient Investigator-Initiated Trial (IIT) of Epetraborole in Patients with M. abscessus Lung Disease
-
Ionis well-positioned for continued momentum and substantial value creation in 2026 with two new independent launches and several pivotal data readouts
-
Utz Brands, Inc. Announces Preliminary Fourth Quarter and Fiscal Year 2025 Results
-
Shake Shack Provides Fiscal Fourth Quarter 2025 Business Update
-
REPEAT/MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight
-
SAGA Diagnostics® Launches Ultrasensitive Pathlight™ MRD Test in Colorectal Cancer
-
Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026
-
Aeva to Participate in the 28th Annual Needham Growth Conference
-
Ono to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
Northwestern Medicine Selects Tempus to Expand Genomic Testing
-
Vince Holding Corp. Provides Holiday Sales Results
-
SmartCella and Catalent Sign Nonexclusive License Agreement for GMP iPSCs
-
Neurogene Announces Recent Achievements and Anticipated 2026 Key Milestones for NGN-401, a Potential Best-in-Class Gene Therapy for Rett Syndrome
-
Subaru Selects Dynamic Map Platform’s HD Map Data for New Advanced EyeSight® Driver Assist Technology
-
Everseen Unveils Everact: The First Agentic AI Platform for Conversational Retail Intelligence
-
Mobileye Announces Timing of its Fourth Quarter and Full Year 2025 Results
-
Bristol Myers Squibb Announces Positive Topline Results from Phase 3 SCOUT-HCM Trial Evaluating Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
-
Healthpeak Properties Announces $925 Million of Transaction Activity
-
Reed Duchscher Appointed to Funko Board of Directors
-
Genesco Reports Comparable Sales
-
Study Shows NuScale Power Technology Can Support Profitable, Reliable Power for Chemical Plants
-
Spire Global Successfully Launches 9 Satellites on SpaceX’s Twilight Mission
-
OneSpaWorld Announces Preliminary Fourth Quarter and Fiscal Year 2025 Revenue and Adjusted EBITDA and Introduces Fiscal 2026 Revenue and Adjusted EBITDA Guidance
-
Booz Allen Announces Partnership with Andreessen Horowitz to Accelerate and Scale Advanced Technology for Governments
-
ShareBuilder 401k Empowers the Self-Employed With Free Solo 401(k) Setup to Start the New Year
-
US Foods Reaffirms Fiscal Year 2025 Guidance
-
J.Jill, Inc. Raises Fourth Quarter Guidance Ahead of the 28th Annual ICR Conference
